Moderna (MRNA) Says Dr. Slaoui Resigned From Board to Join White House’s Operation Warp Speed Initiative
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Moderna Congratulates Dr. Moncef Slaoui on His Appointment to Oversee the White House’s Operation Warp Speed Initiative
May 15, 2020 12:53 PM EDTCAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Dr. Moncef Slaoui has resigned from Modernas Board of Directors upon appointment of his new role to oversee the White Houses Operation Warp Speed initiative. Dr. Slaoui joined Modernas Board of Directors in 2017.
I would like to thank Moncef for his critical insights and three years of service on the Moderna Board, said Noubar Afeyan, Ph.D.,... More
